- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00993161
Upper Limb Evaluation in Non Ambulatory Patients With Neuromuscular Disorder (ULENAP)
October 10, 2017 updated by: Institut de Myologie, France
Development and Evaluation of a Clinical Test in Order Quantify Muscular Function in Upper Limb of Non Ambulatory Patients With Neuromuscular Disorder
The aim of this study is to evaluate different devices to quantify upper limb function (Motriplate) and strength (Myogrip, Myopinch) in non-ambulatory patients with neuromuscular disorder.
Motriplate measures the ability of the patient to reproduce a repetitive movement of the wrist to push two 5cm*5cm targets during 30 seconds.
One hundred patients aged 8-30 years and 60 controls will be evaluated during twelve months (M0, M6 and M12) with theses new tools, and results will be compared to other testing, such as wrist, grip and pinch strength, taping, MFM measurement, and self evaluation of hand ability.
Study Overview
Study Type
Interventional
Enrollment (Actual)
174
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Garches, France, 92000
- Hôpital Raymond Poincaré
-
Paris, France, 75013
- Institut de Myologie
-
Paris, France, 75012
- Trousseau
-
Paris, France, 75015
- NECKER
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 30 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Confirmed neuromuscular disorder
- Aged 8-30 years
- Written consent
- Non ambulant
Exclusion Criteria
- Major cognitive impairment
- Inability to stay seated one hour
- Recent upper limb surgery or trauma
- Treatment by steroids initiated less than 6 months before
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: patients
Patients with neuromuscular disorder and controls
|
Number of contact couples
|
Experimental: Controls
healthy controls
|
Number of contact couples
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of contact couples with the targets
Time Frame: Month 0, Day 60, Month 6, Month 12
|
Month 0, Day 60, Month 6, Month 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Mercuri E, Mayhew A, Muntoni F, Messina S, Straub V, Van Ommen GJ, Voit T, Bertini E, Bushby K; TREAT-NMD Neuromuscular Network. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th--13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June--1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord. 2008 Nov;18(11):894-903. doi: 10.1016/j.nmd.2008.07.003. Epub 2008 Sep 24. No abstract available.
- Seferian AM, Moraux A, Canal A, Decostre V, Diebate O, Le Moing AG, Gidaro T, Deconinck N, Van Parys F, Vereecke W, Wittevrongel S, Annoussamy M, Mayer M, Maincent K, Cuisset JM, Tiffreau V, Denis S, Jousten V, Quijano-Roy S, Voit T, Hogrel JY, Servais L. Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial. PLoS One. 2015 Apr 10;10(4):e0121799. doi: 10.1371/journal.pone.0121799. eCollection 2015.
- Seferian AM, Moraux A, Annoussamy M, Canal A, Decostre V, Diebate O, Le Moing AG, Gidaro T, Deconinck N, Van Parys F, Vereecke W, Wittevrongel S, Mayer M, Maincent K, Desguerre I, Themar-Noel C, Cuisset JM, Tiffreau V, Denis S, Jousten V, Quijano-Roy S, Voit T, Hogrel JY, Servais L. Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial. PLoS One. 2015 Feb 2;10(2):e0113999. doi: 10.1371/journal.pone.0113999. eCollection 2015.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2010
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
May 1, 2013
Study Registration Dates
First Submitted
October 9, 2009
First Submitted That Met QC Criteria
October 9, 2009
First Posted (Estimate)
October 12, 2009
Study Record Updates
Last Update Posted (Actual)
October 11, 2017
Last Update Submitted That Met QC Criteria
October 10, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ULENAP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Disorders
-
Linde AGCompletedFunctional Test, COPD, Neuromuscular Disorders, Mechanical Ventilation, Weaning, DisabilityArgentina, Colombia, Germany
-
Brugmann University HospitalCompletedAnesthesia, General | Neuromuscular Transmission DisordersBelgium
-
St. Louis UniversityCompletedNeurological Disorders | Neuromuscular DisordersUnited States
-
Centre d'Investigation Clinique et Technologique...Association Française contre les Myopathies (AFM), Paris; Fondation GarchesCompletedAdult Patients With Neuromuscular Disorders Using WheelchairFrance
-
Centre d'Investigation Clinique et Technologique...CompletedRespiratory Failure | Neuromuscular DisorderFrance
-
Hacettepe UniversityCompleted
-
Centre d'Investigation Clinique et Technologique...Adep AssistanceCompletedRespiratory Failure | Mechanical Ventilation | Swallowing | Neuromuscular DisorderFrance
-
Stamford HospitalWithdrawnColorectal Disorders | Observation of Neuromuscular BlockUnited States
-
Centre d'Investigation Clinique et Technologique...UnknownRespiratory Failure | Neuromuscular Disorder | Diaphragmatic ParalysisFrance